Close
  Indian J Med Microbiol
 

Figure 2: Patients with no lesions, mild (<10 lesions), moderate (11–49 lesions), and severe scabies (>50 lesions) at baseline and follow-up in the Group A, topical ivermectin group (n = 51). P < 0.001 at 1st and 2nd weeks

Figure 2: Patients with no lesions, mild (<10 lesions), moderate (11–49 lesions), and severe scabies (>50 lesions) at baseline and follow-up in the Group A, topical ivermectin group (<i>n</i> = 51). <i>P</i> < 0.001 at 1<sup>st</sup> and 2<sup>nd</sup> weeks